Officials from a delegation of the China Council for Promotion of International Trade are looking to invest in pharmaceutical production projects in Pakistan, according to the Pakistan Times. The Pakistani government is reportedly offering major incentives to foreign investors, including many tax benefits, as well as a large internal market of 128 million people. Pakistan is also considered to be an important gateway to markets in Central Asia.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze